|
gptkbp:instanceOf
|
gptkb:person
|
|
gptkbp:advisorTo
|
gptkb:UK_Government_Vaccine_Taskforce
gptkb:UK_Life_Sciences_Industrial_Strategy
|
|
gptkbp:almaMater
|
gptkb:University_of_Alberta
gptkb:University_of_Oxford
|
|
gptkbp:award
|
gptkb:Fellow_of_the_Royal_Society
gptkb:Knight_Bachelor
gptkb:Order_of_the_Companions_of_Honour
|
|
gptkbp:birthDate
|
1952-07-02
|
|
gptkbp:birthPlace
|
gptkb:Edmonton,_Alberta,_Canada
|
|
gptkbp:boardMemberOf
|
gptkb:Genomics_England
gptkb:Regeneron_Pharmaceuticals
gptkb:Roche
|
|
gptkbp:children
|
2
|
|
gptkbp:citizenship
|
gptkb:Canada
gptkb:United_Kingdom
|
|
gptkbp:degree
|
Doctor of Medicine
|
|
gptkbp:editor
|
gptkb:Nature_Reviews_Immunology
|
|
gptkbp:education
|
gptkb:Magdalen_College,_Oxford
gptkb:University_of_Alberta
|
|
gptkbp:employer
|
gptkb:University_of_Oxford
|
|
gptkbp:fieldOfWork
|
biomedical research
genetics
immunology
|
|
gptkbp:fullName
|
gptkb:Sir_John_Irving_Bell
|
|
gptkbp:honorificPrefix
|
gptkb:FMedSci
gptkb:FRS
CH
Sir
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Sir John Bell
|
|
gptkbp:knownFor
|
gptkb:public_policy
leadership in medical research
|
|
gptkbp:memberOf
|
gptkb:Academy_of_Medical_Sciences
gptkb:National_Academy_of_Sciences
gptkb:Royal_Society
|
|
gptkbp:nationality
|
gptkb:Canadian
British
|
|
gptkbp:notableWork
|
gptkb:Human_Genome_Project
gptkb:UK_Biobank
|
|
gptkbp:occupation
|
gptkb:professor
gptkb:researchers
gptkb:immunologist
|
|
gptkbp:position
|
gptkb:Regius_Professor_of_Medicine,_University_of_Oxford
|
|
gptkbp:researchInterest
|
translational medicine
autoimmune disease
genetic susceptibility
|
|
gptkbp:spouse
|
gptkb:Christine_Bell
|
|
gptkbp:thesisTitle
|
The cell surface in B lymphocyte differentiation
|
|
gptkbp:thesisYear
|
1982
|
|
gptkbp:bfsParent
|
gptkb:St_Catherine's_College
gptkb:St_Cross_College
|
|
gptkbp:bfsLayer
|
4
|